{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:36:51Z","timestamp":1780097811630,"version":"3.54.0"},"reference-count":65,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health (NIH)","award":["R01"],"award-info":[{"award-number":["R01"]}]},{"name":"National Institute of Health (NIH)","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}]},{"name":"National Institute of Health (NIH)","award":["UL1 TR001857"],"award-info":[{"award-number":["UL1 TR001857"]}]},{"name":"Clinical and Translational Science Award (CTSA)","award":["R01"],"award-info":[{"award-number":["R01"]}]},{"name":"Clinical and Translational Science Award (CTSA)","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}]},{"name":"Clinical and Translational Science Award (CTSA)","award":["UL1 TR001857"],"award-info":[{"award-number":["UL1 TR001857"]}]},{"name":"University of Colorado","award":["R01"],"award-info":[{"award-number":["R01"]}]},{"name":"University of Colorado","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}]},{"name":"University of Colorado","award":["UL1 TR001857"],"award-info":[{"award-number":["UL1 TR001857"]}]},{"DOI":"10.13039\/100016220","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["R01"],"award-info":[{"award-number":["R01"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["UL1 TR001857"],"award-info":[{"award-number":["UL1 TR001857"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Vitamin D insufficiency and deficiency are highly prevalent in patients with chronic kidney disease (CKD), and their pharmacokinetics are not well described. The primary study objective was to develop a population pharmacokinetic model of oral cholecalciferol (VitD3) and its three major metabolites, 25-hydroxyvitamin D3 (25D3), 1,25-dihydroxyvitamin D3 (1,25D3), and 24,25-dihydroxyvitamin D3 (24,25D3), in CKD patients with vitamin D insufficiency and deficiency. CKD subjects (n = 29) were administered one dose of oral VitD3 (5000 I.U.), and nonlinear mixed effects modeling was used to describe the pharmacokinetics of VitD3 and its metabolites. The simultaneous fit of a two-compartment model for VitD3 and a one-compartment model for each metabolite represented the observed data. A proportional error model explained the residual variability for each compound. No assessed covariate significantly affected the pharmacokinetics of VitD3 and metabolites. Visual predictive plots demonstrated the adequate fit of the pharmacokinetic data of VitD3 and metabolites. This is the first reported population pharmacokinetic modeling of VitD3 and metabolites and has the potential to inform targeted dose individualization strategies for therapy in the CKD population. Based on the simulation, doses of 600 International Unit (I.U.)\/day to 1000 I.U.\/day for 6 months are recommended to obtain the target 25D3 concentration of between 30 and 60 ng\/mL. These simulation findings could potentially contribute to the development of personalized dosage regimens for vitamin D treatment in patients with CKD.<\/jats:p>","DOI":"10.3390\/ijms252212279","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:59:13Z","timestamp":1731653953000},"page":"12279","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Population Pharmacokinetic Model of Vitamin D3 and Metabolites in Chronic Kidney Disease Patients with Vitamin D Insufficiency and Deficiency"],"prefix":"10.3390","volume":"25","author":[{"given":"Stacey M.","family":"Tuey","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avisek","family":"Ghimire","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Guzy","sequence":"additional","affiliation":[{"name":"Pop\u2014Pharm Pharmacometrics Service, Albany, CA 94706, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2887-4615","authenticated-orcid":false,"given":"Linda","family":"Prebehalla","sequence":"additional","affiliation":[{"name":"Center for Clinical Pharmaceutical Sciences, Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandla-Atilano","family":"Roque","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavriel","family":"Roda","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"Raymond E.","family":"West","sequence":"additional","affiliation":[{"name":"Center for Clinical Pharmaceutical Sciences, Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel B.","family":"Chonchol","sequence":"additional","affiliation":[{"name":"Division of Renal Diseases and Hypertension, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine Renal Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-1382","authenticated-orcid":false,"given":"Thomas D.","family":"Nolin","sequence":"additional","affiliation":[{"name":"Center for Clinical Pharmaceutical Sciences, Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie S.","family":"Joy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA"},{"name":"Division of Renal Diseases and Hypertension, University of Colorado, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1529-8019.2009.01286.x","article-title":"Vitamin D metabolism","volume":"23","author":"Lehmann","year":"2010","journal-title":"Dermatol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jones, G. (2010). Metabolism and catabolism of vitamin D, its metabolites and clinically relevant analogs. Vitamin D: Physiology, Molecular Biology, and Clinical Applications, Humana Press.","DOI":"10.1007\/978-1-60327-303-9_4"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1111\/j.1753-4887.2008.00094.x","article-title":"Vitamin D\u2019s role in cell proliferation and differentiation","volume":"66","author":"Samuel","year":"2008","journal-title":"Nutr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcb.10343","article-title":"Vitamin D regulation of the renin\u2014Angiotensin system","volume":"88","author":"Li","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Doan TN, K., Vo, D.K., Kim, H., Balla, A., Lee, Y., Yoon, I.S., and Maeng, H.J. (2020). Differential effects of 1\u03b1, 25-dihydroxyvitamin D3 on the expressions and functions of hepatic CYP and UGT enzymes and its pharmacokinetic consequences in vivo. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111129"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"25125","DOI":"10.1074\/jbc.M201323200","article-title":"Expression of cyp3a4, cyp2b6, andcyp2c9 is regulated by the vitamin d receptor pathway in primary human hepatocytes","volume":"277","author":"Drocourt","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0006-291X(02)02742-0","article-title":"Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements","volume":"299","author":"Thompson","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2012.09.012","article-title":"Interplay between vitamin D and the drug metabolizing enzyme CYP3A4","volume":"136","author":"Wang","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hossein-nezhad, A., and Holick, M.F. (2013). Vitamin D for Health: A Global Perspective, Elsevier.","DOI":"10.1016\/j.mayocp.2013.05.011"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111819","DOI":"10.1016\/j.ecoenv.2020.111819","article-title":"Antagonistic effect of VDR\/CREB1 pathway on cadmium-induced apoptosis in porcine spleen","volume":"209","author":"Zhang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_13","first-page":"V","article-title":"Vitamin d deficiency\u2014An ignored epidemic","volume":"4","author":"Naeem","year":"2010","journal-title":"Int. J. Health Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5414\/CN108182","article-title":"Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population","volume":"82","author":"Ngai","year":"2014","journal-title":"Clin. Nephrol."},{"key":"ref_15","first-page":"12","article-title":"Vitamin D deficiency, bone turnover markers and arterial calcifications in non-dialysis chronic kidney diseaes patients","volume":"20","author":"Chiriac","year":"2024","journal-title":"Acta Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lee, J., Bae, E.H., Kim, S.W., Chung, W., Kim, Y.H., Oh, Y.K., Kim, Y.-S., Oh, K.-H., and Park, S.K. (2023). The association between vitamin D deficiency and risk of renal event: Results from the Korean cohort study for outcomes in patients with chronic kidney disease (KNOW-CKD). Front. Med., 10.","DOI":"10.3389\/fmed.2023.1017459"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Franca Gois, P.H., Wolley, M., Ranganathan, D., and Seguro, A.C. (2018). Vitamin D deficiency in chronic kidney disease: Recent evidence and controversies. Int. J. Environ. Res. Public Health, 15.","DOI":"10.20944\/preprints201807.0320.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ajkd.2015.06.020","article-title":"Kidney function and fracture risk: The Atherosclerosis Risk in Communities (ARIC) study","volume":"67","author":"Daya","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2862","article-title":"Hip fracture in patients with non-dialysis-requiring chronic kidney disease","volume":"31","author":"Kim","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","article-title":"Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice","volume":"9","author":"Souberbielle","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41430-020-0558-y","article-title":"Vitamin D deficiency 2.0: An update on the current status worldwide","volume":"74","author":"Amrein","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","author":"Work","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00228-012-1378-3","article-title":"Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach","volume":"69","author":"Benaboud","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/bcp.12006","article-title":"Vitamin D 3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol","volume":"75","author":"Foissac","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CP202185","article-title":"Population pharmacokinetics of 25-hydroxyvitamin D in healthy young adults","volume":"53","author":"Milovanovic","year":"2015","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10928-016-9465-1","article-title":"Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data","volume":"43","author":"Gastonguay","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10928-017-9525-1","article-title":"Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics","volume":"44","author":"Gastonguay","year":"2017","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","article-title":"The future burden of CKD in the United States: A simulation model for the CDC CKD Initiative","volume":"65","author":"Hoerger","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1989.64","article-title":"Metabolic clearance rate and production rate of calcitriol in uremia","volume":"35","author":"Dusso","year":"1989","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"Massry","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/j.ajkd.2018.06.031","article-title":"The role of vitamin D in CKD stages 3 to 4: Report of a scientific workshop sponsored by the National Kidney Foundation","volume":"72","author":"Melamed","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40620-015-0186-0","article-title":"Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low","volume":"29","author":"Ennis","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Parikh, A., Chase, H.S., Vernocchi, L., and Stern, L. (2014). Vitamin D resistance in chronic kidney disease (CKD). BMC Nephrol., 15.","DOI":"10.1186\/1471-2369-15-47"},{"key":"ref_41","first-page":"5719461","article-title":"Seasonal variation in vitamin D in association with age, inflammatory cytokines, anthropometric parameters, and lifestyle factors in older adults","volume":"2017","author":"Castillo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12020-015-0548-3","article-title":"Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort","volume":"49","author":"Klingberg","year":"2015","journal-title":"Endocrine"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Deb, S., Reeves, A.A., and Lafortune, S. (2020). Simulation of physicochemical and pharmacokinetic properties of vitamin D3 and its natural derivatives. Pharmaceuticals, 13.","DOI":"10.3390\/ph13080160"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jsbmb.2016.08.004","article-title":"Physiological functions of Vitamin D in adipose tissue","volume":"165","author":"Abbas","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/cs0430413","article-title":"The distribution and storage of vitamin D and its metabolites in human tissues","volume":"43","author":"Mawer","year":"1972","journal-title":"Clin. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/EJE-14-0870","article-title":"Vitamin D3 increases in abdominal subcutaneous fat tissue after supplementation with vitamin D3","volume":"172","author":"Didriksen","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/dmd.112.045245","article-title":"Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease","volume":"40","author":"Velenosi","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1681\/ASN.2009080815","article-title":"Reduced hepatic synthesis of calcidiol in uremia","volume":"21","author":"Michaud","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1254\/jphs.08042FP","article-title":"Effect of hemodialysis on hepatic cytochrome P450 functional expression","volume":"108","author":"Michaud","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"582S","DOI":"10.1093\/ajcn\/88.2.582S","article-title":"Pharmacokinetics of vitamin D toxicity","volume":"88","author":"Jones","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/cs0400039","article-title":"The metabolism of isotopically labelled vitamin D3 in man: The influence of the state of vitamin D nutrition","volume":"40","author":"Mawer","year":"1971","journal-title":"Clin. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2265.1992.tb02278.x","article-title":"The role of 1, 25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency","volume":"37","author":"Clements","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2215\/CJN.03130314","article-title":"Decreased conversion of 25-hydroxyvitamin D3 to 24, 25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD","volume":"9","author":"Stubbs","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2012.193","article-title":"The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease","volume":"82","author":"Bosworth","year":"2012","journal-title":"Kidney Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.25","article-title":"An approach for identifiability of population pharmacokinetic\u2013pharmacodynamic models","volume":"2","author":"Shivva","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","article-title":"Enzymes involved in the activation and inactivation of vitamin D","volume":"29","author":"Prosser","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.ajkd.2014.02.015","article-title":"Estimated GFR and circulating 24, 25-dihydroxyvitamin D3 concentration: A participant-level analysis of 5 cohort studies and clinical trials","volume":"64","author":"Sachs","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI111971","article-title":"Evidence for alteration of the vitamin D-endocrine system in obese subjects","volume":"76","author":"Bell","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02555135","article-title":"Low circulating vitamin D in obesity","volume":"43","author":"Liel","year":"1988","journal-title":"Calcif. Tissue Int."},{"key":"ref_61","first-page":"391","article-title":"Relationship between free and total 1, 25-dihydroxyvitamin D in conditions of modified binding","volume":"144","author":"Swinkels","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsbmb.2011.09.002","article-title":"Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease","volume":"128","author":"Doorenbos","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_63","first-page":"510","article-title":"Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease","volume":"36","author":"Luna","year":"2016","journal-title":"Nefrolog\u00eda"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/dmd.121.000609","article-title":"Physiologically Based Pharmacokinetic Modeling of Vitamin D(3) and Metabolites in Vitamin D-Insufficient Patients","volume":"50","author":"Sawyer","year":"2022","journal-title":"Drug Metab. Dispos."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12279\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:07Z","timestamp":1760113987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":65,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252212279"],"URL":"https:\/\/doi.org\/10.3390\/ijms252212279","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}